Survival prediction in diffuse large B-cell lymphoma patients: multimodal PET/CT deep features radiomic model utilizing automated machine learning
Journal of Cancer Research and Clinical Oncology · 09.10.2024 · 150 (10)
DOI: 10.1007/s00432-024-05905-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, online erschienen am 09.10.2024. Verfasst von Jianxin Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory of Broadband Wireless Communication and Sensor Network Technology (Ministry of Education), Nanjing University of Posts and Telecom…. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Positron Emission Tomography Computed Tomography, Machine Learning. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nanjing Drum Tower Hospital, the Key Project of Medical Science and Technology of Nanjing.
Abstract (Originalsprache)
PURPOSE: We sought to develop an effective combined model for predicting the survival of patients with diffuse large B-cell lymphoma (DLBCL) based on the multimodal PET-CT deep features radiomics signature (DFR-signature). METHODS: 369 DLBCL patients from two medical centers were included in this study. Their PET and CT images were fused to construct the multimodal PET-CT images using a deep learning fusion network. Then the deep features were extracted from those fused PET-CT images, and the DFR-signature was constructed through an Automated machine learning (AutoML) model. Combined with clinical indexes from the Cox regression analysis, we constructed a combined model to predict the progression-free survival (PFS) and the overall survival (OS) of patients. In addition, the combined model was evaluated in the concordance index (C-index) and the time-dependent area under the ROC curve (tdAUC). RESULTS: A total of 1000 deep features were extracted to build a DFR-signature. Besides the DFR-signature, the combined model integrating metabolic and clinical factors performed best in terms of PFS and OS. For PFS, the C-indices are 0.784 and 0.739 in the training cohort and internal validation cohort, respectively. For OS, the C-indices are 0.831 and 0.782 in the training cohort and internal validation cohort. CONCLUSIONS: DFR-signature constructed from multimodal images improved the classification accuracy of prognosis for DLBCL patients. Moreover, the constructed DFR-signature combined with NCCN-IPI exhibited excellent potential for risk stratification of DLBCL patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Key Laboratory of Broadband Wireless Communication and Sensor Network Technology (Ministry of Education), Nanjing University of Posts and Telecommunications, Nanjing, China. chenjx@njupt.edu.cn.
- The Key Laboratory of Broadband Wireless Communication and Sensor Network Technology (Ministry of Education), Nanjing University of Posts and Telecommunications, Nanjing, China.
Förderung
- Nanjing Drum Tower Hospital
- the Key Project of Medical Science and Technology of Nanjing
Zitieren
APA
Chen, J., Lin, F., Dai, Z., Chen, Y., Fan, Y., Li, A., & Zhao, C. (2024). Survival prediction in diffuse large B-cell lymphoma patients: multimodal PET/CT deep features radiomic model utilizing automated machine learning. Journal of Cancer Research and Clinical Oncology, 150(10). https://doi.org/10.1007/s00432-024-05905-0
Vancouver
Chen J, Lin F, Dai Z, Chen Y, Fan Y, Li A, et al. Survival prediction in diffuse large B-cell lymphoma patients: multimodal PET/CT deep features radiomic model utilizing automated machine learning. Journal of Cancer Research and Clinical Oncology. 2024;150(10). doi:10.1007/s00432-024-05905-0
BibTeX
@article{Chen2024,
author = {Chen, Jianxin and Lin, Fengyi and Dai, Zhaoyan and Chen, Yu and Fan, Yawen and Li, Ang and Zhao, Chenyu},
title = {Survival prediction in diffuse large B-cell lymphoma patients: multimodal PET/CT deep features radiomic model utilizing automated machine learning},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
volume = {150},
number = {10},
doi = {10.1007/s00432-024-05905-0}
}
EUVIMED